Jeff Yass’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-76,800
Closed -$5.35M 13558
2024
Q3
$5.35M Buy
76,800
+32,000
+71% +$2.19M ﹤0.01% 3487
2024
Q2
$3.01M Sell
44,800
-103,000
-70% -$6.94M ﹤0.01% 4296
2024
Q1
$10.2M Buy
147,800
+117,900
+394% +$7.96M ﹤0.01% 2580
2023
Q4
$1.86M Buy
+29,900
New +$1.67M ﹤0.01% 5520
2023
Q2
Sell
-4,500
Closed -$246K 13387
2023
Q1
$246K Sell
4,500
-7,700
-63% -$450K ﹤0.01% 10163
2022
Q4
$763K Sell
12,200
-8,900
-42% -$591K ﹤0.01% 6780
2022
Q3
$1.49M Buy
21,100
+12,900
+157% +$890K ﹤0.01% 5622
2022
Q2
$465K Buy
8,200
+1,500
+22% +$82.2K ﹤0.01% 8458
2022
Q1
$419K Sell
6,700
-3,900
-37% -$210K ﹤0.01% 9425
2021
Q4
$594K Sell
10,600
-6,800
-39% -$416K ﹤0.01% 8716
2021
Q3
$1.13M Sell
17,400
-19,300
-53% -$1.32M ﹤0.01% 7240
2021
Q2
$2.33M Buy
36,700
+500
+1% +$29.5K ﹤0.01% 5591
2021
Q1
$2.17M Sell
36,200
-6,200
-15% -$337K ﹤0.01% 5727
2020
Q4
$2.12M Sell
42,400
-113,300
-73% -$5.32M ﹤0.01% 4974
2020
Q3
$7.95M Buy
155,700
+90,600
+139% +$3.78M ﹤0.01% 2481
2020
Q2
$2.29M Sell
65,100
-27,800
-30% -$957K ﹤0.01% 4255
2020
Q1
$2.36M Buy
92,900
+62,300
+204% +$1.85M ﹤0.01% 3685
2019
Q4
$848K Buy
+30,600
New +$730K ﹤0.01% 5853

Other funds holding AXNX

Jeff Yass's AXNX Position: Q4 2024 in Review

Jeff Yass sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 13,288 shares — an estimated $925K sold.

Jeff Yass first reported a position in AXNX in Q2 2019 and held it in 21 quarters. The position peaked at $3.67M in Q3 2020. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Jeff Yass reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Jeff Yass sold 13,288 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $925K.
  • Jeff Yass first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
  • Jeff Yass's Axonics, Inc. Common Stock position peaked at $3.67M in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.